Great Lakes Retirement’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,871
Closed -$763K 215
2024
Q4
$763K Buy
8,871
+575
+7% +$62.2K 0.1% 156
2024
Q3
$988K Buy
8,296
+384
+5% +$51.2K 0.13% 146
2024
Q2
$1.13M Buy
7,912
+1,755
+29% +$233K 0.15% 127
2024
Q1
$791K Buy
+6,157
New +$733K 0.12% 151

Other funds holding NVO

Great Lakes Retirement's NVO Position: Q1 2025 in Review

Great Lakes Retirement sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 8,871 shares — an estimated $763K sold.

Great Lakes Retirement first reported a position in NVO in Q1 2024 and held it in 4 quarters. The position peaked at $1.13M in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Great Lakes Retirement reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Great Lakes Retirement sold 8,871 Novo Nordisk shares in Q1 2025, an estimated $763K.
  • Great Lakes Retirement first reported a position in Novo Nordisk in Q1 2024 and held it in 4 quarters.
  • Great Lakes Retirement's Novo Nordisk position peaked at $1.13M in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Great Lakes Retirement's 13F filing for Q1 2025, filed 17 Apr 2025.